Health

Wissenschaftliche Publikation

Secukinumab, a novel anti-IL-17A antibody, can be quantified in skin after a single dose by dermal open flow microperfusion (dOFM)

Publikation aus Health

Bruin G., Dragatin C. , Aigner B., Polus F., Calonder C., Froeliger C., DIin Katrin Tiffner, DI Manfred Bodenlenz, Mader J., Korsatko S., Ratzer R., Univ.-Prof. Dr. Thomas Pieber, Loesche C., Priv.-Doz. DI Dr. Frank Sinner

Journal der Deutschen Dermatologischen Gesellschaft 12:15-15, 2014